AstraZeneca makes deal with White House to lower drug prices

AstraZeneca CEO Pascal Soriot shakes hands pinch President Trump successful nan Oval Office connected Friday, arsenic Health and Human Services Secretary Robert F. Kennedy Jr. looks on. Andrew Harnik/Getty Images hide caption

toggle caption

Andrew Harnik/Getty Images

AstraZeneca became nan 2nd drugmaker to participate a woody pinch nan Trump management to connection little prices to Medicaid and to connection immoderate of its narcotics astatine a discount done TrumpRx, a authorities website to facilitate income straight to consumers.

"In different words nan lowest value anyplace successful nan world, that's what we get," President Trump said during an Oval Office property convention Friday. The centerpiece of nan woody is most-favored-nation pricing for narcotics sold to Medicaid. That would nexus Medicaid prices to nan little ones paid successful different developed countries.

As portion of nan deal, AstraZeneca will besides connection discounts of up to 80% disconnected database prices connected nonstop income to consumers, according to a institution statement. Its narcotics see inhalers for illustration Bevespi Aerosphere for group pinch COPD and Airsupra for group pinch asthma. AstraZeneca, based successful nan U.K., besides said it would grow supplier manufacturing and investigation successful nan U.S.

In return for these commitments, nan supplier institution will get a three-year exemption from definite tariffs.

The White House unveiled its scheme for TrumpRx and a akin deal pinch Pfizer connected Sept. 30. The website will thief patients entree narcotics astatine little prices — bypassing wellness insurance.

TrumpRx is portion of a broader inaugural nan management says is aimed astatine bringing prices paid by Americans much successful statement pinch those paid successful different developed countries.

The announcement follows an executive bid successful May, and letters to 17 pharmaceutical companies sent retired complete nan summertime to push them to little prices voluntarily.

The TrumpRx website is expected to motorboat sometime successful 2026, and would return consumers to pharmaceutical companies' direct-to-consumer websites to fulfill orders.

The effect of nan Trump management deals pinch pharmaceutical companies for consumers is unclear. Medicaid and its beneficiaries, for instance, already salary immoderate of nan lowest prices for drugs. And group pinch wellness security could walk little connected their medicines done copays than buying them straight from AstraZeneca.

AstraZeneca besides said Thursday that it would put an further $500 cardinal successful a caller manufacturing installation successful Virginia, raising nan finance to $4.5 billion. That's portion of a $50 cardinal finance announced successful July to grow manufacturing accommodation successful California, Indiana, Maryland, Massachusetts, Texas and Virginia, arsenic good arsenic different investigation and improvement efforts.

"For each nan pharmaceutical companies retired location — we're talking to each of you, prime up a shovel," said Dr. Mehmet Oz, who leads nan Centers for Medicare and Medicaid Services, during nan property conference.

Trump said his management had gotten a full of $18 trillion full commitments to re-shore pharmaceutical manufacturing. NPR wasn't instantly capable to independently corroborate that number.